-
Innovation Ranking
NewInnovation Ranking – Guangdong Fenghua Advanced Technology Holding Co Ltd
Guangdong Fenghua Advanced Technology Holding Co Ltd (Guangdong Fenghua) is a manufacturer and supplier of high-end new components, electronic materials, and electronic special equipment. The company’s product portfolio includes capacitors, resistors, inductors, semiconductor devices, integrated circuits, electronic devices, magnetic components, electronic materials, electronic equipment, and radio frequency devices. It also carries out research and development of basic electronic information products. The company’s products are used in consumer electronics, communication, computer and intelligent terminal, automotive electronics, power and industrial control. It...
-
Sector Analysis
NewAutomotive Advanced xEV Batteries Market Trends, Sector Overview and Forecast to 2028
Automotive Advanced xEV Batteries Market Report Overview The advanced xEV batteries market size was 26.8 million units in 2023. The market will grow at a CAGR of more than 14% during 2023-2028. There was a fluctuation in demand for essential materials owing to the surge In recent years, there has been a significant increase in the adoption of electric vehicles (EVs) and Hybrid Electric Vehicles (HEVs) across the world. Moreover, governments worldwide are incentivizing automakers and consumers to shift towards...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pradusinstobart in Advanced Malignancy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pradusinstobart in Advanced Malignancy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pradusinstobart in Advanced Malignancy Drug Details: Pradusinstobart is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Adebrelimab in Advanced Malignancy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Adebrelimab in Advanced Malignancy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adebrelimab in Advanced Malignancy Drug Details: Adebrelimab (Ariely) is a humanized...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AMXI-5001 in Advanced Malignancy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AMXI-5001 in Advanced Malignancy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AMXI-5001 in Advanced Malignancy Drug Details: AMXI-5001 is under development for the...
-
Product Insights
SK Geo Centric – Ulsan Advanced Recycling Cluster – Ulsan
The SK Geo Centric – Ulsan Advanced Recycling Cluster – Ulsan project involves the construction of a plastic waste recycling plant in Ulsan, South Korea. Equip yourself with the essential tools needed to make informed and profitable decisions with our SK Geo Centric – Ulsan Advanced Recycling Cluster – Ulsan report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and...
-
Product Insights
Advanced Glycosylation End Product Specific Receptor – Drugs In Development, 2023
Global Markets Direct’s Advanced Glycosylation End Product Specific Receptor provides in depth analysis on Advanced Glycosylation End Product Specific Receptor targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dalnicastobart in Advanced Malignancy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dalnicastobart in Advanced Malignancy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dalnicastobart in Advanced Malignancy Drug Details: Dalnicastobart (LVGN-7409) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pimicotinib in Advanced Malignancy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Pimicotinib in Advanced Malignancy Drug Details: Pimicotinib (ABSK-021) is under development for the treatment of...
-
Analyst Opinions
Advanced Biometrics – Emerging Trends and Technologies in Authentication
Advanced Biometrics Trend Analysis Report Overview Biometrics is the practice of using unique physical or behavioral traits for identification and authentication purposes. Its usage has been increasing day by day. Fingerprint recognition, voice recognition, facial recognition, palm recognition, iris recognition, and behavioral biometrics are some of its key modalities. For instance, iris recognition is often used in high-security applications such as border control and access to secure facilities. The "Advanced Biometrics - Emerging Trends and Technologies in Authentication" report offers...